Oler Abraham N.'s Form 4 filing
Traws Pharma, Inc. (TRAW) · filed Sep 29, 2021
- Accession no.
- 0001179110-21-008982
- Filed
- Sep 29, 2021
- Trade date
- Sep 28, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $10.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Oler Abraham N.CIK 0001557372 | Officer (SVP Corp Dev & Gen Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2021 | Common Stock | PPurchaseAcquired | +2,381 | $4.20 | +$10,000.2 | 12,515 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.